Literature DB >> 33369273

Effects of trans- versus cis-resveratrol on adrenergic contractions of the rat tail artery and role of endothelium.

Ian R VanAntwerp1, Laura E Phelps1, Jacob D Peuler1, Phillip G Kopf1.   

Abstract

The health benefits of the natural polyphenol trans-resveratrol may play an important role in preventing a variety of diseases. Resveratrol has been shown to reduce blood pressure and improve metabolic diseases such as type 2 diabetes mellitus and obesity. Our previous studies examined the role of K+ channels in the vasorelaxation responses to trans-resveratrol in the rat tail artery. During these studies, we uncovered a novel transient contraction prior to the sustained relaxation effect of trans-resveratrol. Thus, the purpose of this study was to determine the role of the endothelium in these vascular contraction and relaxation responses to trans-resveratrol. We additionally sought to determine if the cis-isomer of resveratrol exerts any of the same vascular effects as the trans-isomer. The vascular responses to trans-resveratrol were examined in rat tail arteries with intact or denuded endothelium over a 2-hr period. Additionally, the vascular responses to trans- and cis-resveratrol were compared in rat tail arteries with intact endothelium. Both the transient contractile response and the persistent relaxation response to trans-resveratrol were similar in the arterial rings with intact or denuded endothelium. There was a significant correlation between the initial contraction-enhancing action of trans-resveratrol and the magnitude of the sustained relaxation for vessels with both intact and denuded endothelium. Moreover, we demonstrated that cis-resveratrol produced a significantly greater relaxation response as compared to trans-resveratrol without the initial contractile response. These data demonstrate the role of the vascular smooth muscle in the vascular responses to resveratrol and the potential clinical benefits of the cis-isomer of resveratrol as compared to the trans-isomer.
© 2020 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society.

Entities:  

Keywords:  adrenergic contractions; cis-isomer; endothelium; rat tail artery; resveratrol

Year:  2021        PMID: 33369273      PMCID: PMC7758980          DOI: 10.14814/phy2.14666

Source DB:  PubMed          Journal:  Physiol Rep        ISSN: 2051-817X


  62 in total

1.  Evidence of direct smooth muscle relaxant effects of the fibrate gemfibrozil.

Authors:  Laura E Phelps; Jacob D Peuler
Journal:  J Smooth Muscle Res       Date:  2010

Review 2.  Endothelial function: cardiac events.

Authors:  Amir Lerman; Andreas M Zeiher
Journal:  Circulation       Date:  2005-01-25       Impact factor: 29.690

3.  Resveratrol improves cardiovascular function in DOCA-salt hypertensive rats.

Authors:  Vincent Chan; Andrew Fenning; Abishek Iyer; Andrew Hoey; Lindsay Brown
Journal:  Curr Pharm Biotechnol       Date:  2011-03-01       Impact factor: 2.837

4.  Resveratrol improves cardiovascular function and reduces oxidative organ damage in the renal, cardiovascular and cerebral tissues of two-kidney, one-clip hypertensive rats.

Authors:  Hale Z Toklu; Ozer Sehirli; Mehmet Erşahin; Selami Süleymanoğlu; Omer Yiğiner; Ebru Emekli-Alturfan; Ayşen Yarat; Berrak Ç Yeğen; Göksel Sener
Journal:  J Pharm Pharmacol       Date:  2010-10-04       Impact factor: 3.765

5.  Pressure-induced myogenic activation of cat cerebral arteries is dependent on intact endothelium.

Authors:  D R Harder
Journal:  Circ Res       Date:  1987-01       Impact factor: 17.367

6.  Relaxant and antioxidant capacity of the red wine polyphenols, resveratrol and quercetin, on isolated mice corpora cavernosa.

Authors:  Charlotte Boydens; Bart Pauwels; Kelly Decaluwé; Peter Brouckaert; Johan Van de Voorde
Journal:  J Sex Med       Date:  2014-12-02       Impact factor: 3.802

7.  Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis.

Authors:  Victoria A Brown; Ketan R Patel; Maria Viskaduraki; James A Crowell; Marjorie Perloff; Tristan D Booth; Grygoriy Vasilinin; Ananda Sen; Anna Maria Schinas; Gianfranca Piccirilli; Karen Brown; William P Steward; Andreas J Gescher; Dean E Brenner
Journal:  Cancer Res       Date:  2010-10-08       Impact factor: 12.701

8.  Contribution of nitric oxide, cyclic GMP and K+ channels to acetylcholine-induced dilatation of rat conduit and resistance arteries.

Authors:  O L Woodman; O Wongsawatkul; C G Sobey
Journal:  Clin Exp Pharmacol Physiol       Date:  2000 Jan-Feb       Impact factor: 2.557

Review 9.  Properties of Resveratrol: In Vitro and In Vivo Studies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans.

Authors:  J Gambini; M Inglés; G Olaso; R Lopez-Grueso; V Bonet-Costa; L Gimeno-Mallench; C Mas-Bargues; K M Abdelaziz; M C Gomez-Cabrera; J Vina; C Borras
Journal:  Oxid Med Cell Longev       Date:  2015-06-28       Impact factor: 6.543

Review 10.  Anti-Oxidant, Anti-Inflammatory and Anti-Angiogenic Properties of Resveratrol in Ocular Diseases.

Authors:  Allan Lançon; Raffaele Frazzi; Norbert Latruffe
Journal:  Molecules       Date:  2016-03-02       Impact factor: 4.411

View more
  1 in total

1.  Antioxidant Activity of Resveratrol Diastereomeric Forms Assayed in Fluorescent-Engineered Human Keratinocytes.

Authors:  Ilaria Bononi; Paola Tedeschi; Vanessa Mantovani; Annalisa Maietti; Elisa Mazzoni; Cecilia Pancaldi; Vincenzo Brandolini; Mauro Tognon
Journal:  Antioxidants (Basel)       Date:  2022-01-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.